|
ANAPC7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.119860E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.342600E-03 |
| Normal-vs-Stage2 |
7.989400E-01 |
| Normal-vs-Stage3 |
1.013330E-04 |
| Normal-vs-Stage4 |
3.3297000001653E-07 |
| Stage1-vs-Stage2 |
9.077800E-02 |
| Stage1-vs-Stage3 |
3.690400E-02 |
| Stage1-vs-Stage4 |
2.625900E-04 |
| Stage2-vs-Stage3 |
8.816700E-03 |
| Stage2-vs-Stage4 |
5.182700E-04 |
| Stage3-vs-Stage4 |
1.322020E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.957800E-04 |
| Normal-vs-AfricanAmerican |
2.654100E-02 |
| Normal-vs-Asian |
8.860300E-02 |
| Caucasian-vs-AfricanAmerican |
8.657200E-01 |
| Caucasian-vs-Asian |
2.649800E-01 |
| AfricanAmerican-vs-Asian |
5.015000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.174800E-04 |
| Normal-vs-Female |
6.361800E-03 |
| Male-vs-Female |
3.289700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.881400E-03 |
| Normal-vs-Age(41-60Yrs) |
4.203500E-03 |
| Normal-vs-Age(61-80Yrs) |
2.941500E-03 |
| Normal-vs-Age(81-100Yrs) |
2.892000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.133800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.979600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.081800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.033600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.300800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.796400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.158500E-02 |
| Classical-VS-Follicular |
7.602700E-03 |
| Classical-VS-Other |
2.878100E-02 |
| Classical-VS-Normal |
9.167600E-04 |
| Tall-VS-Follicular |
4.209600E-04 |
| Tall-VS-Other |
7.302200E-01 |
| Tall-VS-Normal |
7.66320000000764E-05 |
| Follicular-VS-Other |
4.190300E-04 |
| Follicular-VS-Normal |
8.784000E-01 |
| Other-VS-Normal |
1.817390E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.633760E-02 |
| Normal-vs-N1 |
1.8565199999987E-05 |
| N0-vs-N1 |
7.141200E-03 |
|
|
